Gregory Gould

Gregory Gould

Director of Finance/CFO at ACLARION, INC.

Net worth: 164 000 $ as of 31/05/2026

60 year
Health Technology
Consumer Services
Technology Services

Profile

Gregory A. Gould is currently Chief Financial Officer at Aclarion, Inc. since 2025.
Former positions include President, CEO, CFO, Secretary & Treasurer at SeraCare Life Sciences, Inc. in 2012; Independent Director at CytoDyn, Inc. from 2013 to 2019; Chief Financial Officer, Secretary & Treasurer at Ampio Pharmaceuticals, Inc. from 2014 to 2017; Chief Financial Officer, Secretary & Treasurer at Aytu Biopharma, Inc. from 2015 to 2017; Chief Financial Officer-Therapure Products at Evolve Biologics, Inc. from 2017 to 2018; Chief Financial & Administrative Officer at Partner Co. from 2018 to 2021; Chief Financial & Administration Officer at Charlotte's Web Holdings, Inc. in 2022; Chief Financial Officer & Senior Vice President at Integrated BioPharma, Inc. in 2005; Chief Financial Officer, Secretary & Treasurer at Atrix Laboratories, Inc. from 2004 to 2005; Chief Financial Officer & Treasurer at Colorado MEDtech, LLC from 1996 to 2003; Chief Financial Officer at Rosewind Corp.; and Auditor at Arthur Andersen LLP.
Education includes undergraduate studies at the University of Colorado Boulder.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
11/06/2026 50,000 ( 2.03% ) 164 000 $ 31/05/2026

Gregory Gould active positions

CompaniesPositionStart
ACLARION, INC. Director of Finance/CFO 02/09/2025

Former positions of Gregory Gould

CompaniesPositionEnd
CHARLOTTE'S WEB HOLDINGS, INC. Director of Finance/CFO 31/12/2022
NEWAGE, INC. Director of Finance/CFO 02/07/2021
CYTODYN INC. Chairman 17/06/2013
Director of Finance/CFO 01/10/2018
AYTU BIOPHARMA, INC. Director of Finance/CFO 15/11/2017
See the detail of Gregory Gould's experience

Training of Gregory Gould

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

51

1st degree connections

14

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies14

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Technology Services

Health Technology

Commercial Services

Health Technology

Consumer Services

Health Technology

Retail Trade

Process Industries

Health Technology

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!